Dumping Bayer

|
About: Bayer Aktiengesellschaft (BAYRY), BAYZF
by: Patrick Kroneman
This article is exclusive for subscribers.
Patrick Kroneman
Value, research analyst, long/short equity, contrarian
Summary

Roundup cases keeps growing.

Balance sheet needs improvement.

Management mishandled the Monsanto acquisition.

Hope for change is a bad investment thesis.

Recently I removed Bayer (OTCPK:BAYRY, OTCPK:BAYZF) from my portfolio. The primary reason for doing so is the mismanagement of the company. While there still is chance of upside in the stock, appreciation